Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.51% | -16.52% | 96.74% | -93.43% | 40.08% |
| Total Depreciation and Amortization | -5.87% | -5.89% | -1.02% | -19.34% | -19.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 251.94% | 205.61% | -405.26% | 1,076.84% | -135.14% |
| Change in Net Operating Assets | -128.08% | -453.50% | -124.39% | 622.64% | 231.48% |
| Cash from Operations | -56.66% | -20.27% | -91.90% | 48.85% | 38.98% |
| Capital Expenditure | -- | -- | -175.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -110.89% | -99.72% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 8,371.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 9,124.82% | 10,708.70% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.75% | -23.66% | 692.08% | -193.48% | -269.03% |